How AI Is Changing Access to Cancer Clinical Trials

Reading time: 5 minutes Charles Okila, MPH Clinical trials provide an avenue for many patients suffering from cancer to obtain access to new therapies and more intensive care. However, only a small percentage of cancer patients participate in these clinical trials. The lack of participation is seldom a matter of unwillingness. Instead, it is the... Continue Reading →

Create a website or blog at WordPress.com

Up ↑